Strategies to Improve Guideline Concordant Care and Clinical Trial Access for Lung Cancer Patients in the United States
Purpose
The goal of this program is to implement scalable, community-focused models that increase adherence to guideline-recommended testing and treatments, and expand equitable clinical trial access and enrollment.
Scope
This Request for Proposals (RFP) intends to fund innovative and scalable approaches to improve the care of lung cancer patients by improving the uptake and utilization of guideline-concordant care, and improving access to clinical trials. Projects of interest would include, but are not limited to:
- Leveraging technology, including electronic health records and artificial intelligence, to improve adherence to testing and treatment recommendations, and identify potential clinical trial participants.
- Establish or enhance multi-disciplinary team approaches to ensure patients receive comprehensive and timely care across the disease continuum.
- Patient-centered approaches (e.g. mobile health tools and other technologies) to help patients adhere to care guidelines, understand their options regarding clinical trials, and engage in shared-decision making with their providers.
- Implementation of decentralized clinical trial models to promote access beyond traditional “research hubs.”
This grant program is a collaboration between AstraZeneca and EveryGrant® powered by Conquer Cancer, designed expressly to meet the needs of lung cancer patients and care providers. Conquer Cancer acts as the primary administrator for the review and evaluation of applications. Grant funding will be provided directly to recipients by AstraZeneca.
For more information about this funding opportunity and to download the Request for Proposals (RFP), please click here.
If you have questions regarding this RFP, please direct them in writing to Conquer Cancer Director of Scientific Review, Andrew L. Smith, PhD (Andrew.Smith@conquer.org), Lynn Kayali, PharmD (lynn.kayali@astrazeneca.com), or Ilker Arslan, MD (Ilker.Arslan@astrazeneca.com).
To start an application, you must create an account by clicking Register at the top right-hand corner of the page and following the instructions on the next page.
If you already have an account, click Log-in.
Under Programs, select the AstraZeneca Quality Improvement Grant for Lung Cancer and click Apply.
AstraZeneca Quality Improvement Grant for Lung Cancer
Strategies to Improve Guideline Concordant Care and Clinical Trial Access for Lung Cancer Patients in the United States
Purpose
The goal of this program is to implement scalable, community-focused models that increase adherence to guideline-recommended testing and treatments, and expand equitable clinical trial access and enrollment.
Scope
This Request for Proposals (RFP) intends to fund innovative and scalable approaches to improve the care of lung cancer patients by improving the uptake and utilization of guideline-concordant care, and improving access to clinical trials. Projects of interest would include, but are not limited to:
- Leveraging technology, including electronic health records and artificial intelligence, to improve adherence to testing and treatment recommendations, and identify potential clinical trial participants.
- Establish or enhance multi-disciplinary team approaches to ensure patients receive comprehensive and timely care across the disease continuum.
- Patient-centered approaches (e.g. mobile health tools and other technologies) to help patients adhere to care guidelines, understand their options regarding clinical trials, and engage in shared-decision making with their providers.
- Implementation of decentralized clinical trial models to promote access beyond traditional “research hubs.”
This grant program is a collaboration between AstraZeneca and EveryGrant® powered by Conquer Cancer, designed expressly to meet the needs of lung cancer patients and care providers. Conquer Cancer acts as the primary administrator for the review and evaluation of applications. Grant funding will be provided directly to recipients by AstraZeneca.
For more information about this funding opportunity and to download the Request for Proposals (RFP), please click here.
If you have questions regarding this RFP, please direct them in writing to Conquer Cancer Director of Scientific Review, Andrew L. Smith, PhD (Andrew.Smith@conquer.org), Lynn Kayali, PharmD (lynn.kayali@astrazeneca.com), or Ilker Arslan, MD (Ilker.Arslan@astrazeneca.com).
To start an application, you must create an account by clicking Register at the top right-hand corner of the page and following the instructions on the next page.
If you already have an account, click Log-in.
Under Programs, select the AstraZeneca Quality Improvement Grant for Lung Cancer and click Apply.